Barclays lowered the firm’s price target on PSEG (PEG) to $88 from $98 and keeps an Overweight rating on the shares post the Q3 report. The firm sees the share underperformance as a buying opportunity. The share reaction seems overdone relative to PSEG’s long term path of nuclear optimization, the analyst tells investors in a research note.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PEG:
- PSEG Reports Strong Q3 2024 Financial Results
- Charged: Nuclear stocks slide after expansion of Amazon data center blocked
- Talen slides as regulators reject proposal to expand Amazon data center
- Unusually active option classes on open November 4th
- PSEG Reports Strong Q3 Earnings and Future Investments